flumazenil has been researched along with Dejerine-Thomas Syndrome in 3 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilman, S | 1 |
| Koeppe, RA | 1 |
| Junck, L | 1 |
| Kluin, KJ | 1 |
| Lohman, M | 1 |
| St Laurent, RT | 1 |
| Ivanov, I | 1 |
| Atkinson, D | 1 |
| Litvinenko, I | 1 |
| Angelova, L | 1 |
| Andonova, S | 1 |
| Mumdjiev, H | 1 |
| Pacheva, I | 1 |
| Panova, M | 1 |
| Yordanova, R | 1 |
| Belovejdov, V | 1 |
| Petrova, A | 1 |
| Bosheva, M | 1 |
| Shmilev, T | 1 |
| Savov, A | 1 |
| Jordanova, A | 1 |
| Schwabova, J | 1 |
| Brozkova, DS | 1 |
| Petrak, B | 1 |
| Mojzisova, M | 1 |
| Pavlickova, K | 1 |
| Haberlova, J | 1 |
| Mrazkova, L | 1 |
| Hedvicakova, P | 1 |
| Hornofova, L | 1 |
| Kaluzova, M | 1 |
| Fencl, F | 1 |
| Krutova, M | 1 |
| Zamecnik, J | 1 |
| Seeman, P | 1 |
1 review available for flumazenil and Dejerine-Thomas Syndrome
| Article | Year |
|---|---|
Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.
Topics: Adolescent; Bulgaria; Child; Child, Preschool; Exosome Multienzyme Ribonuclease Complex; Female; Gen | 2018 |
2 other studies available for flumazenil and Dejerine-Thomas Syndrome
| Article | Year |
|---|---|
Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography.
Topics: Adult; Aged; Cerebellar Diseases; Female; Flumazenil; Humans; Male; Middle Aged; Olivopontocerebella | 1995 |
Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma.
Topics: Czech Republic; Exosome Multienzyme Ribonuclease Complex; Female; Haplotypes; Homozygote; Humans; In | 2013 |